Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atham Ali

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Experimental Hematology|December 17, 2021
CD99 in malignant hematopoiesisAtham Ali, Vijaya Pooja Vaikari, Houda Alachkar
Pharmacology & Therapeutics|April 3, 2021
Strategies targeting FLT3 beyond the kinase inhibitorsMohammed F Almatani, Atham Ali, Sandra Onyemaechi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2024
Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatmentShephali Kadam, Atham Ali, Mateusz Pospiech, et al.
Cellular & Molecular Biology Letters|May 24, 2023
Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironmentYiting Meng, Mateusz Pospiech, Atham Ali, et al.
Cancer Research Communications|July 15, 2024
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid LeukemiaAtham Ali, Alvin Phan, Vijaya Vaikari, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
αB-Crystallin Peptide Fused with Elastin-like Polypeptide: Intracellular Activity in Retinal Pigment Epithelial Cells Challenged with Oxidative StressSara Aly Attia, Anh Tan Truong, Alvin Phan, et al.
Lab Animal|July 10, 2026
Establishment and functional analysis of an inducible Apoc2-knockout mouse model to investigate the role of Apoc2 in normal hematopoiesisXiaochen Zhang, Ritu Chandwani, Mateusz Pospiech, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Experimental Hematology|December 17, 2021
CD99 in malignant hematopoiesisAtham Ali, Vijaya Pooja Vaikari, Houda Alachkar
Pharmacology & Therapeutics|April 3, 2021
Strategies targeting FLT3 beyond the kinase inhibitorsMohammed F Almatani, Atham Ali, Sandra Onyemaechi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2024
Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatmentShephali Kadam, Atham Ali, Mateusz Pospiech, et al.
Cellular & Molecular Biology Letters|May 24, 2023
Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironmentYiting Meng, Mateusz Pospiech, Atham Ali, et al.
Cancer Research Communications|July 15, 2024
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid LeukemiaAtham Ali, Alvin Phan, Vijaya Vaikari, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
αB-Crystallin Peptide Fused with Elastin-like Polypeptide: Intracellular Activity in Retinal Pigment Epithelial Cells Challenged with Oxidative StressSara Aly Attia, Anh Tan Truong, Alvin Phan, et al.
Lab Animal|July 10, 2026
Establishment and functional analysis of an inducible Apoc2-knockout mouse model to investigate the role of Apoc2 in normal hematopoiesisXiaochen Zhang, Ritu Chandwani, Mateusz Pospiech, et al.
Pageof 1